byiShook Opinion
Mar 21, 2025 - 13:40
Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra. The post Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio appeared first on Investor's Business Daily.
Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.
The post Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio appeared first on Investor's Business Daily.